ENDOMETRIAL THICKNESS AND ESTRADIOL CONCENTRATION IN WOMEN WITH BLEEDING COMPLAINTS DURING USE OF NORPLANT(R) IMPLANTS

Citation
A. Faundes et al., ENDOMETRIAL THICKNESS AND ESTRADIOL CONCENTRATION IN WOMEN WITH BLEEDING COMPLAINTS DURING USE OF NORPLANT(R) IMPLANTS, Human reproduction, 13(1), 1998, pp. 188-191
Citations number
26
Categorie Soggetti
Reproductive Biology","Obsetric & Gynecology
Journal title
ISSN journal
02681161
Volume
13
Issue
1
Year of publication
1998
Pages
188 - 191
Database
ISI
SICI code
0268-1161(1998)13:1<188:ETAECI>2.0.ZU;2-J
Abstract
The objective of this study was to measure oestradiol, progesterone an d endometrial development among Norplant(R) implant users with bleedin g complaints, Seventy-six volunteers complaining of prolonged/frequent bleeding were enrolled. Oestradiol, progesterone and endometrial thic kness (assessed by vaginal ultrasound) were determined at that visit, Two thirds of the women had low oestradiol (<50 pg/ml) and all except one had low progesterone concentrations (<3 ng/ml), A total of 68% had a very thin endometrium (<3 mm). A subgroup of 21 women were followed twice a week for 8 consecutive weeks, Oestradiol and progesterone con centrations remained low during the continuous bleeding episodes or sh ort bleeding-free intervals (less than or equal to 15 days), yet incre ased five-to sixfold (253.4 +/- 142.2 pg/ml) in long bleeding-free int ervals. Endometrial thickness remained thin irrespective of the differ ences in bleeding patterns and oestradiol. We conclude that Norplant(R ) implant users with bleeding complaints are usually characterized by low oestradiol concentrations, absence of luteal activity and thin end ometrium. A good correlation exists with increasing oestradiol concent rations and longer bleeding-free intervals, but this is not manifested by increased endometrial thickness. However, few subjects bleed with relatively high oestradiol concentrations, therefore a better understa nding of the intimate disturbances related to endometrial bleeding in users of long-acting progestins is still pending.